3-Chloro-4-(3-Fluorobenzyloxy)aniline CAS 202197-26-0 Lapatinib Intermedia Puritas >98.0% (HPLC)
Shanghai Ruifu Chemical Co., Ltd. est primarius fabrica 3-Chloro-4-(3-Fluorobenzyloxy)anilineorum (CAS: 202197-26-0) magna qualitate.Ruifu Chemical traditio totius terrarum, quantitatis competitive pretium, optimum servitium, parvas et moles in promptu habere potest.Purchase Lapatinib Mediis,Please contact: alvin@ruifuchem.com
Nomen chemicum | 3-Chloro-4-(3-Fluorobenzyloxy)aniline |
Synonyma | 3-Chloro-4-[(3-Fluorophenyl)methoxy]anilineum;4-(3-Fluorobenzyloxy)-3-Chlorobenzenamine;Lapatinib medium B |
Stock Status | In Stock, Commercial Productio |
CAS Number | 202197-26-0 |
Formulae hypotheticae | C13H11ClFNO |
M. Pondus | 251.69 g/mol |
Liquescens punctum | 78.0 ad 82.0℃ |
Density | 1.306±0.06 g/cm3 |
COA & MSDS | Praesto |
Sample | Praesto |
Origin | Shanghai, China |
Brand | Ruifu Chemical |
Items | Signa inspectionis | Proventus |
Aspectus | Brown ad nigrum pulveris | Obsequitur |
Liquescens punctum | 78.0 ad 82.0℃ | 80.7℃ |
Damnum in Siccatio | <1.00% | Obsequitur |
Residere in Ignition | <0.50% | Obsequitur |
Related immunditias ab HPLC | <2.00% | 0.64% |
Puritas / Analysis Methodus | >98.0% (HPLC) | 99.36% |
1H NMR Imaginum | Congruunt Structure | Obsequitur |
conclusio | Productum probatum est et cum datis specificationibus obsequitur | |
Applicationem | Ditosylate Monohydratorum |
Sarcina:Fluorinated Utrem, aluminium ffoyle, 25kg/cardboard Drum, vel secundum exigentiam emptoris.
Repono Condition:Continentem arcte clausam et in frigido, sicco et bene ventilato horreis a substantiis incompossibilibus repone.A luce et humore protege.
Naviportans:Libera ad mundum ab aere, per FedEx / DHL Express.Ieiunium et certas traditiones provide.
Quam mercari?Quaeso contactumDr. Alvin Huang: sales@ruifuchem.com or alvin@ruifuchem.com
15 Years Experience?Plus quam XV annos experientiae habemus in fabricando et exportando amplis intermediis pharmaceuticis vel alchimicis pharmaceuticis amplis.
Mercatus principalis?Vendere mercatum domesticum, Americam septentrionalem, Europam, Indiam, Coream, Iaponicam, Australiam etc.
Commodi?Superior qualitas, parabilis pretium, officia professionalia et subsidia technica, ieiunium partus.
Qualitasfides?Qualitas strictioris temperantiae ratio.Pro instrumento analysi professionali includuntur NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, KF, ROI, LOD, MP, Claritas, Solubilitas, Microbialis limes test, etc.
Exempla?Pleraque producta praebent exempla gratuita pro qualitate aestimationis, sumptus naviculas a clientibus solvendos.
Factory Audit?Factory audit gratissimum.Quaeso ante constitutum.
MOQ?Nec MOQ.Parvus ordo placet.
Tempus adferendi? Si intus prosapia, tres dies partus praestatur.
Transportatio?Per Express (FedEx, DHL), ab Air, per Mare.
Documenta?Post servitium venditionis: COA, MOA, ROS, MSDS, etc. praeberi possunt.
Consuetudo Synthesis?Consuetudo synthesis officia praebere potest ad optimas investigationes tuas necessitates aptandas.
Pensio conditio?Proforma cautionis primum post confirmationem ordinis mittetur, informationes nostrae ripae inclusas.Payment by T/T (Telex Transfer), PayPal, Western Union, etc.
UN IDs 3077
HS Codex 2921420090
Aleam Class IX
Stipare Group III
3-Chloro-4-(3-Fluorobenzyloxy)anilineum (CAS: 202197-26-0) medium est in synthesi Lapatinib / Lapatinib Ditosylate Monohydratorum.
Lapatinib medicamentum est cancer pectoris impressi a GlaxoSmithKline Co. Humani ErbB receptores humani receptatores generis I tyrosini kinasi (TK) receptoris familiae, incluso ErbB1 (EGFR), ErbB2 (HER2), ErbB3 (HER3), et ErbB4 (HER4) .Receptores ErbB-I (EGFR) et ErbB-2 (ER-2) receptores saepe expressi vel aliter in aegros cancer mutati sunt.Humanum auctum epidermalis factor receptoris 2 (ErbB-2, HER-2) notum est hominem esse oncogene cum cancro pectori propinqua.Altitudo eius expressio in cancro pectori saepe metastasim nodi lymphatici praedicat et differentiam tumoris pauperis, cum prognosi paupere.HER-2 una e scoporum moleculis pro justo carcinomate specialium.eodem tempore agere potest Lapatinib Her-utraquc 1 Her-2.Effectus biologici huius methodi inhibentes prolificationem et incrementum cellularum tuberculorum multo maiores sunt quam solum unum scopum agentes.Compositum Lapatinib cum Capecitabine aegros cum carcinomate metastatico provecto vel carcinomate praecedente tractare cum receptore 2 epidermali humano, cum anthracyclinis, paclitaxel et trastuzumab iam tractatis.Cuscicae probationes ostenderunt Lapatinib etiam efficacius HER2-type aegros cum resistentia cancri Herceptini tractare.
-
Lapatinib Base CAS 231277-92-2 Puritas ≥99.0% (H...
-
Lapatinib Ditosylate Monohydrate CAS 388082-78-...
-
3-Chloro-4-(3-Fluorobenzyloxy)aniline CAS 20219...
-
Sodium Methanesulfinate CAS 20277-69-4 Munditia >...
-
2-Aminoethyl Methyl Sulfone Hydrochloride CAS 1...
-
4-Chloro-6-Iodoquinazoline CAS 98556-31-1 Purit...
-
6-Iodo-4-Hydroxyquinazoline CAS 16064-08-7 Puri...
-
5-Formyl-2-Furanboronic Acidum CAS 27329-70-0 Pur...
-
Lapatinib Intermediate CAS 231278-84-5 Puritas >...